CEFTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ceftin, and when can generic versions of Ceftin launch?
Ceftin is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in CEFTIN is cefuroxime axetil. There are sixty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ceftin
A generic version of CEFTIN was approved as cefuroxime axetil by APOTEX on October 2nd, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFTIN?
- What are the global sales for CEFTIN?
- What is Average Wholesale Price for CEFTIN?
Summary for CEFTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Patent Applications: | 1,030 |
| Drug Prices: | Drug price information for CEFTIN |
| DailyMed Link: | CEFTIN at DailyMed |
US Patents and Regulatory Information for CEFTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | CEFTIN | cefuroxime axetil | FOR SUSPENSION;ORAL | 050672-001 | Jun 30, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | TABLET;ORAL | 050605-002 | Dec 28, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | FOR SUSPENSION;ORAL | 050672-002 | Apr 29, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | TABLET;ORAL | 050605-001 | Dec 28, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | TABLET;ORAL | 050605-003 | Dec 28, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
